Treviamet Xr Tablets 100Mg/1000Mg (1 Box = 2 Strips) (1 Strip = 7 Tablets)
100Mg 1000MgRxDIABETES

Treviamet Xr

Treviamet Xr Tablets 100Mg/1000Mg (1 Box = 2 Strips) (1 Strip = 7 Tablets)

Metformin

GETZ PHARMA PAKISTAN (PVT) LTD. Box 14 units

Drug Identity

Active Ingredient
Metformin
Chemical Class
Biguanide
Pharmacological Group
on the basis of mechanism of action and also cl...
ATC Code
A10BA02
Status
Essential Medicine

What is Treviamet Xr?

Uses
Metformin (HCl) is oral biguanide antidiabetic agent, introduced in 1950s. It reduces elevated blood glucose concentration in diabetic pa...

How It Works

Chemical Class
Biguanide
Pharmacological Group
on the basis of mechanism of action and also classified in Antidiabetic Agent, Biguanide pharmacological group

Metformin is the derivative of Metformin (HCl). It is of Synthetic origin and belongs to Biguanide. It belongs to Hypoglycemic pharmacological group on the basis of mechanism of action and also classified in Antidiabetic Agent, Biguanide pharmacological group. The Molecular Weight of Metformin (HCl) is 165.62. Its pKa is 11.5.

How to Take It

1
Adult · PO
500 to 3000 mg — 12 hourly
Frequency may be increased upto 3times/day, if needed. Gradually increase upto 2-3 g/day.
2
Child
Not recommended in this age group

Safety Alerts

Metformin (HCl) is contraindicated in conditions like Alcohol dependence, Anemia, Myocardial infarction, Septicemia, Infections, Respiratory disease, Ketosis, Cardiovascular disease, Diabetic coma, Trauma, Liver damage, Iron deficiency, Vitamin B12 deficiency, Renal impairment, Diabetic retinopathy

Important Warnings

Metformin should be used with caution in patients with pre-existing liver disease, kidney disease, heart trouble or if have any allergy, infections
Avoid excessive use of alcohol while taking this
It is not recommended for use during pregnancy and should be used only if clearly needed during lactation

Side Effects

The severe or irreversible adverse effects of Metformin (HCl)which give rise to further complications include VasculitisPneumonitisMalabsorption of vit B12Malabsorption of folic acidMegaloblastic anemiaHypoglycemia. Metformin (HCl) produces potentially life-threatening effects which include Lactic Acidosis. which are responsible for the discontinuation of Metformin (HCl) therapy. The symptomatic adverse reactions produced by Metformin (HCl) are more or less tolerable and if they become severethey can be treated symptomaticallythese include Abdominal distensionFlatulenceNauseaVomitingAnorexiaDiarrheaSkin reactions

Drug Interactions

Metformin (HCl) is known to interact with other drugs
the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAcarboseAcarbose and guar gum both decrease the absorption of metformin.AlcoholEthanol initiate effects of metformin on lactate metabolism.ModerateAvoid intake of alcohol and notify the signs of lactic acidosis like malaise
respiratory distress
somnolence and irregular heart beat.Amiloride (HCl)Amiloride compete with metformin for renal tubular transport thus decreases excretion of metformin leads risk of lactic acidosis.ModerateMonitor patient glucose level and adjust metformin dose.AtenololAtenolol enhance the hypoglycemic effect of metformin.ModerateMonitoring of patient blood glucose level should be done when these drugs are coadministered.Chlorpromazine (HCl)Chlorpromazine decreases the hypoglycemic effect of metformin by interfering with blood glucose control. ModerateClosely monitor the blood glucose level. Adjust the dose of metformin accordingly.Cimetidine (HCl)Cimetidine decreases the renal tubular secretion of metformin result in increased AUC upto 50% and decreases the plasma clearence upto 27% reult in increased plasma level may lead to lactic acidosis.ModerateSlowly reduce the dose of metformin. Monitor thr blood glucose level regularly. Patient should notify to physician if experience any sign of lactic acidosis.DigoxinDigoxin decreases the excretion of metformin by competing the renal tubular transport.ModerateDose of metformin should be reduced.Dolutegravirdolutegravir may increased the level of metforminclose monitoring and dose adjustment recommendedFrusemide or FurosemideFurosemide increases the plasma concentration while mwtformin decreases the peak concentration and elimination half life upto 31%and 32%respectively. Increase plasma level of metformin increases the risk of lactic acidosis.ModerateClosely monitor blood glucose level Patient should notify to physician if experience signs of lactic acidosisGlibenclamideHydrochlorothiazideThiazide (hydrochlorothiazide) antagonize the effect of metformin.Insulin AspartMetformin potentiate the hypoglycemic effect of insulin by increasing cellular mechanism controlled by insulin.ModerateClosely monitor the development of hypoglycaemia in patient.IoxaglateAdministration of intravascular iodinated radiocontrast media in patients treated with biguanides such as metformin may precipitate lactic acidosis
a rare but potentially serious and fatal complication of biguanide therapy. Iodinated contrast material can cause acute alterations in renal function
including acute renal failure
which is a known risk factor for biguanide-induced lactic acidosis.MajorBiguanide therapy should be temporarily discontinued at the time of
or prior to

Storage

Tab Store in a well closed container, Between 15°C-30°C. Protect from Moisture.

Price Intelligence

Rs 731.92
DVAGO observed price · per pack of 14 · as of 30 July 2026
Rs 52.28 per unit
No approved ceiling matched to this exact pack and strength.
Prices across sources
DVAGOper pack of 14Rs 731.92

Should you consider an alternative?

Other options containing Metformin, and what they are not.You pay Rs 416 more than the cheapest equivalent

Identical active ingredient at the same strength. Cheapest per unit first.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

Often Bought Together

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.